Abstract:Background: tRNA-derived RNA fragments (tRFs) are a novel class of small ncRNA that are derived from precursor or mature tRNAs. Recently, the general relevance of their roles and clinical values in tumorigenesis, metastasis, and recurrence have been increasingly highlighted. However, there has been no specific systematic study to elucidate any potential clinical significance for these tRFs in prostate adenocarcinoma (PRAD), one of the most common and malignant cancers that threatens male health worldwide. Here, we investigate the clinical value of 5′-tRFs in PRAD. Methods: Small RNA sequencing data were analyzed to discover new 5′-tRFs biomarkers for PRAD. Machine learning algorithms were used to identify 5′-tRF classifiers to distinguish PRAD tumors from normal tissues. LASSO and Cox regression analyses were used to construct 5′-tRF prognostic predictive models. NMF and consensus clustering analyses were performed on 5′-tRF profiles to identify molecular subtypes of PRAD. Results: The overall levels of 5′-tRFs were significantly upregulated in the PRAD tumor samples compared to their adjacent normal samples. tRF classifiers composed of 13 5′-tRFs achieved AUC values as high as 0.963, showing high sensitivity and specificity in distinguishing PRAD tumors from normal samples. Multiple 5′-tRFs were identified as being associated with the PRAD prognosis. The tRF score, defined by a set of eight 5′-tRFs, was highly predictive of survival in PRAD patients. The combination of tRF and Gleason scores showed a significantly better performance than the Gleason score alone, suggesting that 5′-tRFs can offer PRAD patients additional and improved prognostic information. Four molecular subtypes of the PRAD tumor were identified based on their 5′-tRF expression profiles. Genetically, these 5′-tRFs PRAD tumor subtypes exhibited distinct genomic landscapes in tumor cells. Clinically, they showed marked differences in survival and clinicopathological features. Conclusions: 5′-tRFs are potential clinical biomarkers for the diagnosis, prognosis, and classification of tumor subtypes on a molecular level. These can help clinicians formulate personalized treatment plans for PRAD patients and may have similar potential applications for other disease types.

tRFUniverse: A comprehensive resource for the interactive analyses of tRNA-derived ncRNAs in human cancer

Oncotrf: An Online Resource For Exploration Of Trna-Derived Fragments In Human Cancers

Global Identification and Characterization of Trna-Derived RNA Fragment Landscapes Across Human Cancers

tsRFun: a comprehensive platform for decoding human tsRNA expression, functions and prognostic value by high-throughput small RNA-Seq and CLIP-Seq data

Trf2cancer: A Web Server to Detect Trna-Derived Small Rna Fragments (trfs) and Their Expression in Multiple Cancers

tRNA-derived RNA fragments in cancer: current status and future perspectives

Tric: a User-Friendly Data Portal to Explore the Expression Landscape of Trnas in Human Cancers.

Screening and Comprehensive Analysis of Cancer-Associated tRNA-Derived Fragments

tsRNAsearch: a pipeline for the identification of tRNA and ncRNA fragments from small RNA-sequencing data

Research advances of tRNA-derived fragments in tumors

CTRR-ncRNA: A Translation-oriented Knowledgebase for Cancer Resistance and Recurrence Associated Non-coding RNAs

Trna-Derived RNA Fragments Are Novel Biomarkers for Diagnosis, Prognosis, and Tumor Subtypes in Prostate Cancer

tRNA‐derived fragments: Unveiling new roles and molecular mechanisms in cancer progression

CTRR-ncRNA: A Knowledgebase for Cancer Therapy Resistance and Recurrence Associated Non-coding RNAs.

Trftar: Prediction of Trf-Target Gene Interactions Via Systemic Re-Analysis of Argonaute CLIP-seq Datasets.

TransfoRNA: Navigating the Uncertainties of Small RNA Annotation with an Adaptive Machine Learning Strategy

Transfer RNA-derived Small RNAs in Tumor Microenvironment

Role of Trna-Derived Fragments in Cancer: Novel Diagnostic and Therapeutic Targets Trfs in Cancer.

Comprehensive Analysis of a tRNA-Derived Small RNA in Colorectal Cancer

tRFTars: predicting the targets of tRNA-derived fragments

Emerging roles of tRNA-derived fragments in cancer